BIORA THERAPEUTICS, INC. (BIOR) Operating Income (Loss) USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Biora Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2024.
  • Biora Therapeutics, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$15.5 M, a 0.18% increase year-over-year.
  • Biora Therapeutics, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$67.1 M, a 16.9% decline year-over-year.
  • Biora Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$67.1 M, a 8.68% decline from 2022.
  • Biora Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$61.8 M, a 47.6% increase from 2021.
  • Biora Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$118 M, a 9.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$67.1 M -$15.5 M +$28 K +0.18% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$67.1 M -$13.3 M +$432 K +3.14% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 -$67.6 M -$23.3 M -$9.43 M -67.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$58.1 M -$14.9 M -$724 K -5.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$57.4 M -$15.5 M +$4.36 M +21.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$61.8 M -$13.8 M +$6.38 M +31.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$68.2 M -$13.9 M +$16.7 M +54.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$84.8 M -$14.2 M +$21.4 M +60.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$106 M -$19.9 M +$11.6 M +36.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$118 M -$20.2 M +$31.2 M +60.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$149 M -$30.6 M +$105 K +0.34% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$149 M -$35.7 M -$9.17 M -34.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$140 M -$31.5 M +$21.1 M +40.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$161 M -$51.4 M -$2.4 M -4.9% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-18
Q3 2020 -$159 M -$30.7 M +$24.2 M +44.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$183 M -$26.5 M -$12.2 M -85.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$171 M -$52.5 M -$30.5 M -139% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$140 M -$49 M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-18
Q3 2019 -$54.8 M Jul 1, 2019 Sep 30, 2019 10-K 2021-03-18
Q2 2019 -$14.3 M Apr 1, 2019 Jun 30, 2019 10-K 2021-03-18
Q1 2019 -$22 M Jan 1, 2019 Mar 31, 2019 10-K 2021-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.